Key Takeaways Phibro Animal Health (PAHC) shares climbed 76.4% in a year, showcasing impressive momentum. The stock has outpaced the industry's 4.9% growth and the S&P 500 Composite's 16% gain. With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment. Phibro shares jumped 76.4% in a year, beating industry and S&P 500 growth. PAHC's revenue gains came from Mineral Nutrition and Performance Products. PAHC's ...